Clinical Report: Synchronous Bilateral Breast Cancer with Different Histologies
Overview
This report details a case of synchronous bilateral breast cancer in a 51-year-old woman, revealing two distinct histological types: invasive breast carcinoma with apocrine differentiation and multifocal mucinous carcinoma.
Background
Synchronous bilateral breast cancer is a rare occurrence, representing 1%–5% of all breast cancer cases, and presents unique challenges in diagnosis and treatment. The presence of different pathological and molecular subtypes complicates clinical management.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
A 51-year-old woman was diagnosed with synchronous bilateral breast cancer.
The right breast lesion was identified as invasive breast carcinoma with apocrine differentiation, while the left breast contained multifocal mucinous carcinoma.
Intraoperative frozen pathology confirmed bilateral malignancy, leading to a bilateral mastectomy.
The patient received a comprehensive treatment regimen including TAC chemotherapy and capecitabine maintenance therapy.
At 31 months postoperatively, the patient remained disease-free with no signs of recurrence.
Clinical Implications
This case illustrates the necessity for thorough imaging and pathological evaluations in patients with synchronous bilateral breast cancer.
Conclusion
This case report highlights the management of a patient with synchronous bilateral breast cancer exhibiting distinct histological types.
Each year, the American Society of Clinical Oncology Annual Meeting brings together cancer specialists from around the world to share the research most likely to shape the next chapter of cancer care. This year’s major updates point to several important themes: more precise treatment, smarter use of surgery and chemotherapy, new approaches for difficult-to-treat cancers and a growing recognition that supportive care, including exercise, can be part of cancer treatment planning.
